MedPath

HUGEL AUSTRALIA PTY. LTD.

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

TGA:2

Drug Approvals

LETYBO (letibotulinumtoxinA) 50 U, Powder for injection (370012)

Product Name
LETYBO (letibotulinumtoxinA) 50 U Powder for injection
Approval Date
Nov 28, 2022
TGA

LETYBO (letibotulinumtoxinA) 100 U, Powder for injection (370011)

Product Name
LETYBO (letibotulinumtoxinA) 100 U, Powder for injection
Approval Date
Nov 28, 2022
TGA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.